ESMYA 5 MG TABLETS Ισραήλ - Αγγλικά - Ministry of Health

esmya 5 mg tablets

cts ltd - ulipristal acetate - tablets - ulipristal acetate 5 mg - ulipristal - pre operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

NORLEVO Ισραήλ - Αγγλικά - Ministry of Health

norlevo

cts ltd - levonorgestrel - tablets - levonorgestrel 1.5 mg - levonorgestrel - levonorgestrel - emergency contraceptive.

NORLEVO Ισραήλ - Αγγλικά - Ministry of Health

norlevo

cts ltd - levonorgestrel - tablets - levonorgestrel 1.5 mg - levonorgestrel - levonorgestrel - emergency contraceptive.

Wound hydrogel dressing, non-sterile Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

wound hydrogel dressing, non-sterile

orion laboratories pty ltd t/a perrigo australia - 47763 - wound hydrogel dressing, non-sterile - non-sterile self-adhesive hydrocolloid dressings for short-term use to protect and manage the micro-environment of superficial wounds and promote healing.

Atropine Sulfate Aguettant 0.1 mg/ml solution for injection in pre-filled syringe Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

atropine sulfate aguettant 0.1 mg/ml solution for injection in pre-filled syringe

laboratoire aguettant - atropine sulfate monohydrate - solution for injection in pre-filled syringe - 0.1 milligram(s)/millilitre - belladonna alkaloids, tertiary amines; atropine - belladonna alkaloids, tertiary amines - atropine sulfate aguettant 0.1 mg/ml, solution for injection in pre-filled syringe is indicated in adults and in paediatric population from birth, but with a body weight superior to 3 kg - as a pre-anaesthetic medication to prevent vagal reactions associated with tracheal intubation and surgical manipulation, - to limit the muscarinic effects of neostigmine, when given postsurgically to counteract non-depolarising muscle relaxants - treatment of hemodynamically compromising bradycardia and/ or atrioventricular block due to excessive vagal tone in emergency situation - cardiopulmonary resuscitation: to treat symptomatic bradycardia and av block - as antidote following overdosage or poisoning with acetylcholinesterase-inhibitors e.g. anticholinesterases, organophosphorus, carbamates and muscarinic mushrooms

Phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe

laboratoire aguettant - phenylephrine hydrochloride - solution for injection in pre-filled syringe - 50 microgram(s)/millilitre - adrenergic and dopaminergic agents; phenylephrine - adrenergic and dopaminergic agent - treatment of hypotension during spinal, epidural or general anesthesia

Testogel 16.2 mg/g, gel Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

testogel 16.2 mg/g, gel

laboratoires besins international - testosterone - gel - 16.2 milligram(s)/gram - 3-oxoandrosten (4) derivatives; testosterone - androgens. - testogel 16.2 mg/g is indicated in adults as testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests

NorLevo 1.5 mg Tablet Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

norlevo 1.5 mg tablet

ltt pharma limited - levonorgestrel - tablet - 1.5 milligram(s) - progestogens; levonorgestrel

Esmya 5 mg Tablet Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

esmya 5 mg tablet

under license from: laboratoire hra pharma; importer: oep philippines, inc.; distributor: zuellig pharma corporation - ulipristal (as acetate) - tablet - 5 mg

Ceplene Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

ceplene

laboratoires delbert - histamine dihydrochloride - leukemia, myeloid, acute - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). the efficacy of ceplene has not been fully demonstrated in patients older than age 60.